Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Carisoprodol:MCnc:Pt:Ser/Plas:Qn

Known as: Karizoprodol:KütlKons:Zml?:Ser/Plaz:Kant, ??????:????:????:??/??:??, Carisoprodol:Massa concentratie:Moment:Serum of plasma:Kwantitatief 
 
National Institutes of Health

Related topics

Related topics

6 relations
CarisoprodolPlasPlasmaSerum
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Randomized, double-blind trial of carisoprodol 250 mg compared with placebo and carisoprodol 350 mg for the treatment of low back spasm
Abstract Background: Carisoprodol, a centrally active skeletal muscle relaxant, is widely used for the treatment of acute… Expand
2010
2010
Bioavailability of oral carisoprodol 250 and 350 mg and metabolism to meprobamate: A single-dose crossover study.
BACKGROUND Carisoprodol is a skeletal muscle relaxant indicated for use in the treatment of acute, painful musculoskeletal… Expand
  • table I
  • table II
  • table III
2008
2008
Double-blind, placebo-controlled trial of carisoprodol 250-mg tablets in the treatment of acute lower-back spasm
ABSTRACT Purpose: The objective of this placebo-controlled trial was to determine the efficacy and safety of carisoprodol (Soma… Expand
2008
2008
Double-blind, placebo-controlled trial of carisoprodol 250-mg tablets in the treatment of acute lower-back spasm.
PURPOSE The objective of this placebo-controlled trial was to determine the efficacy and safety of carisoprodol (Soma, MedPointe… Expand
2008
2008
(205) Double-blind, placebo-controlled studies of carisoprodol 250-mg tablets in the treatment of acute lower back spasm
 
2004
2004
Intoxicación por carisoprodol
 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE